Published in J Antimicrob Chemother on March 14, 2009
Antiviral drug resistance of human cytomegalovirus. Clin Microbiol Rev (2010) 2.70
Congenital cytomegalovirus infection: new prospects for prevention and therapy. Pediatr Clin North Am (2013) 1.40
Human cytomegalovirus infant infection adversely affects growth and development in maternally HIV-exposed and unexposed infants in Zambia. Clin Infect Dis (2012) 1.22
The genetic basis of human cytomegalovirus resistance and current trends in antiviral resistance analysis. Infect Disord Drug Targets (2011) 1.10
Cytomegalovirus: recent progress in understanding pathogenesis and control. QJM (2011) 1.10
Paediatric drug development: are population models predictive of pharmacokinetics across paediatric populations? Br J Clin Pharmacol (2011) 1.03
Cyclopropavir inhibits the normal function of the human cytomegalovirus UL97 kinase. Antimicrob Agents Chemother (2011) 0.98
Oral valganciclovir treatment in newborns with symptomatic congenital cytomegalovirus infection. Eur J Clin Microbiol Infect Dis (2009) 0.97
The search for new therapies for human cytomegalovirus infections. Virus Res (2010) 0.95
Prevention of maternal cytomegalovirus infection: current status and future prospects. Int J Womens Health (2010) 0.95
Screening for congenital cytomegalovirus infection using newborn urine samples collected on filter paper: feasibility and outcomes from a multicentre study. BMJ Open (2011) 0.94
Human cytomegalovirus IE1 protein disrupts interleukin-6 signaling by sequestering STAT3 in the nucleus. J Virol (2013) 0.89
Maintenance of large numbers of virus genomes in human cytomegalovirus-infected T98G glioblastoma cells. J Virol (2014) 0.84
Unusually difficult clinical presentation of an infant suffering from congenital Cytomegalovirus (CMV) infection combined with alpha 1-antitrypsin (A1AT) deficiency. Biochem Med (Zagreb) (2014) 0.83
Oral hexadecyloxypropyl-cidofovir therapy in pregnant guinea pigs improves outcome in the congenital model of cytomegalovirus infection. Antimicrob Agents Chemother (2010) 0.80
Preconception screening for cytomegalovirus: an effective preventive approach. Biomed Res Int (2014) 0.78
Emergence of antiviral resistance during oral valganciclovir treatment of an infant with congenital cytomegalovirus (CMV) infection. J Clin Virol (2013) 0.77
Human Cytomegalovirus interleukin-10 promotes proliferation and migration of MCF-7 breast cancer cells. Cancer Cell Microenviron (2015) 0.76
Synthetic DNA approach to cytomegalovirus vaccine/immune therapy. Adv Exp Med Biol (2015) 0.75
Eye pathologies in neonates. Int J Ophthalmol (2016) 0.75
Gastrointestinal presentation and outcome of perinatal cytomegalovirus infection. BMJ Case Rep (2013) 0.75
Cytomegalovirus infection among infants in California neonatal intensive care units, 2005-2010. J Perinat Med (2014) 0.75
Therapeutic drug monitoring of ganciclovir for postnatal cytomegalovirus infection in an extremely low birth weight infant: a case report. BMC Pediatr (2016) 0.75
Treatment of perinatal viral infections to improve neurologic outcomes. Pediatr Res (2016) 0.75
Characteristics and prognosis of hepatic cytomegalovirus infection in children: 10 years of experience at a university hospital in Korea. Korean J Pediatr (2017) 0.75
Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis (2006) 5.71
Virologic and clinical observations on cytomegalic inclusion disease. N Engl J Med (1962) 5.02
The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. I. N Engl J Med (1971) 4.67
Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med (2001) 3.90
Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol (2004) 3.42
Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr (2003) 3.38
Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA (1986) 3.37
Rise of cytomegalovirus antibodies in an infectious-mononucleosis-like syndrome after transfusion. Br Med J (1966) 3.32
Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr (1997) 2.93
Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol (1995) 2.66
Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J (1992) 2.40
Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. Rev Infect Dis (1983) 2.39
Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J Am Acad Audiol (2000) 2.36
Congenital cytomegalovirus infection. N Engl J Med (1977) 2.35
Breast milk and the risk of cytomegalovirus infection. N Engl J Med (1980) 2.27
Maternal cytomegalovirus excretion and perinatal infection. N Engl J Med (1973) 2.21
A prospective analysis interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts. J Infect Dis (1977) 2.10
A serologic study of cytomegalovirus infections associated with blood transfusions. N Engl J Med (1971) 2.02
Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J Virol (2000) 1.82
Infectious complications of human bone marrow transplantation. Medicine (Baltimore) (1979) 1.74
Cell types involved in replication and distribution of human cytomegalovirus. Adv Virus Res (1996) 1.72
A syndrome following total body perfusion. Surg Gynecol Obstet (1960) 1.71
Human cytomegalovirus cell tropism and pathogenesis. Intervirology (1996) 1.71
Auditory and visual defects resulting from symptomatic and subclinical congenital cytomegaloviral and toxoplasma infections. Pediatrics (1977) 1.66
Cytomegalovirus in human milk. N Engl J Med (1972) 1.60
Cytomegalovirus in semen: observations in selected populations. J Infect Dis (1975) 1.53
Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis (2008) 1.49
Maternal cytomegalovirus infection and perinatal transmission. Clin Obstet Gynecol (1982) 1.46
Congenital and perinatal cytomegalovirus infections. Semin Perinatol (1983) 1.45
Cytomegalovirus infection in day-care center. N Engl J Med (1982) 1.44
Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection. Pediatrics (1997) 1.33
Asymptomatic cytomegalovirus infection following blood transfusion in tumor surgery. JAMA (1970) 1.33
Congenital cytomegalovirus infection and neonatal auditory screening. J Pediatr (1993) 1.31
Lethal cytomegalovirus infection in preterm infants: clinical, radiological, and neuropathological findings. Ann Neurol (1992) 1.25
Thrombocytopenia in murine cytomegalovirus infection. J Lab Clin Med (1973) 1.25
The molecular epidemiology of cytomegalovirus transmission among children attending a day care center. J Infect Dis (1985) 1.24
Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis (1997) 1.24
Congenital cytomegalovirus infection and sensorineural hearing loss. Ear Hear (1985) 1.20
Young children as a probable source of maternal and congenital cytomegalovirus infection. N Engl J Med (1987) 1.19
Febrile postcardiotomy lymphocytic splenomegaly: a new entity. Ann Surg (1962) 1.14
Isolation of cytomegalovirus from toys and hands in a day care center. J Infect Dis (1986) 1.13
Permissive cytomegalovirus infection of primary villous term and first trimester trophoblasts. J Virol (1998) 1.13
Epidemiology of cytomegalovirus infections in young children: day care vs. home care. Pediatr Infect Dis (1985) 1.05
Progressive hearing impairment in children with congenital cytomegalovirus infection. J Speech Hear Disord (1979) 1.04
Congenital cytomegalovirus infection in newborn infants of mothers infected before pregnancy. Arch Dis Child (1978) 0.98
Acquisition of cytomegaloviral infections in families with young children: a serological study. J Infect Dis (1985) 0.97
Cytomegalovirus infection in children undergoing open-heart surgery. Yale J Biol Med (1976) 0.97
Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation. Clin Pharmacol Ther (2007) 0.96
Human trophoblast cells are permissive to the complete replicative cycle of human cytomegalovirus. J Virol (1998) 0.96
Magnetic resonance imaging of the brain in congenital cytomegalovirus infection. Pediatr Radiol (1989) 0.93
Neuroradiographic abnormalities in congenital cytomegalovirus infection. Pediatr Neurol (1989) 0.92
Maribavir: a novel antiviral agent with activity against cytomegalovirus. Ann Pharmacother (2008) 0.91
Survival of cytomegalovirus on environmental surfaces. J Pediatr (1985) 0.91
Ocular abnormalities in congenital cytomegalovirus infection. J Am Optom Assoc (1996) 0.91
Asymptomatic congenital cytomegalovirus infection. Audiologic, neuroradiologic, and neurodevelopmental abnormalities during the first year. Am J Dis Child (1990) 0.90
Cytomegalovirus infections in transplant patients: methods of prevention of primary cytomegalovirus. Transplant Proc (1991) 0.87
Viral diseases of the fetus and newborn. Introduction. Major Probl Clin Pediatr (1978) 0.77
Valacyclovir therapy to reduce recurrent genital herpes in pregnant women. Am J Obstet Gynecol (2006) 1.66
Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients. Clin Infect Dis (2006) 1.46
Varicella zoster virus: natural history and current therapies of varicella and herpes zoster. Herpes (2007) 0.99
Neonatal herpes simplex virus infections: where are we now? Adv Exp Med Biol (2011) 0.93
Issues in regulatory guidelines for data monitoring committees. Clin Trials (2004) 0.88
The spectrum of genital herpes simplex virus infection in men attending a sexually transmitted disease clinic. J Infect Dis (2006) 0.85
Contemporary management of cytomegalovirus infection in transplant recipients: guidelines from an IHMF workshop, 2007. Herpes (2008) 0.83
Current management and recommendations for access to antiviral therapy of herpes labialis. J Clin Virol (2011) 0.82
Predictors of undiagnosed herpes simplex virus type 2 seropositivity among persons attending an HIV care clinic. Sex Transm Dis (2012) 0.79
Herpes simplex virus in African American heterosexual males: the roles of age and male circumcision. Sex Transm Dis (2010) 0.77
Evaluation of the Safety and Biodistribution of M032, an Attenuated HSV-1 Virus Expressing hIL-12, After Intracerebral Administration to Aotus Non-Human Primates. Hum Gene Ther Clin Dev (2014) 0.77
An update on short-course intermittent and prevention therapies for herpes labialis. Herpes (2007) 0.76
Neonatal herpes - the forgotten perinatal infection. Sex Transm Dis (2008) 0.75
Short-course therapy for recurrent genital herpes and herpes labialis. J Fam Pract (2007) 0.75